We are live on ! Find out more
TS

Third Security Portfolio holdings

AUM $241M
1-Year Est. Return 45.43%
This Fund
S&P 500
This Quarter Est. Return
-0.03%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$620M
AUM Growth
-$47.4M
Cap. Flow
-$47.8M
Cap. Flow %
-7.7%
Top 10 Hldgs %
99.97%
Holding
12
New
1
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$2.99M
2
EBS icon
Emergent Biosolutions
EBS
+$207K

Top Sells

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$46.1M
2
FCSC
Fibrocell Science Inc.
FCSC
+$4.89M

Sector Composition

Rank Sector Weight
1 Healthcare 88.14%
2 Energy 8.65%
3 Consumer Staples 3.18%
4 Materials 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PGEN icon
1
Precigen
PGEN
$1.76B
$414M 66.76%
75,514,573
+531,655
+0.7% +$2.99M
HALO icon
2
Halozyme
HALO
$9.23B
$125M 20.15%
7,046,385
-2,659,702
-27% -$46.1M
EPD icon
3
Enterprise Products Partners
EPD
$82.6B
$32M 5.16%
1,135,734
– –
AQB icon
4
AquaBounty Technologies
AQB
$4.99M
$19.7M 3.18%
453,838
– –
ET icon
5
Energy Transfer Partners
ET
$69.9B
$13.8M 2.22%
1,073,990
– –
PTCT icon
6
PTC Therapeutics
PTCT
$6.52B
$6.61M 1.07%
137,551
– –
TCP
7
DELISTED
TC Pipelines LP
TCP
$4.1M 0.66%
97,000
– –
NS
8
DELISTED
NuStar Energy L.P.
NS
$3.75M 0.61%
145,200
– –
OGEN icon
9
Oragenics
OGEN
$2.48M
$809K 0.13%
860
– –
KWR icon
10
Quaker Houghton
KWR
$2.62B
$212K 0.03%
1,290
– –
EBS icon
11
Emergent Biosolutions
EBS
$394M
$206K 0.03%
+3,810
New +$207K
FCSC
12
DELISTED
Fibrocell Science Inc.
FCSC
– –
-1,653,486
Closed -$4.89M

Similar funds

KRC
Kehrs Ridge Capital Holmdel, New Jersey $260M AUM 0.46% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
FG
Foundry Group Boulder, Colorado $209M AUM 47.6% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
UIA
UBP Investment Advisors Geneva, Switzerland $194M AUM 12.96% 1-Year Est. Return
GCM
Gabalex Capital Management New York $181M AUM 9.55% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return

Third Security's Q4 2019 Portfolio in Review

As of Q4 2019, Third Security held 12 positions worth $620M, down 7.1% from $667M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Third Security withdrew a net $47.8M in Q4 2019, closing 1 position and reducing 1 holding. Its most notable exit was Fibrocell Science Inc., an estimated $4.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 88% a quarter earlier, followed by Energy and Consumer Staples.

Against the trend, Third Security opened a new position in Emergent Biosolutions worth $206K.

  • Third Security's largest Q4 2019 buy was Emergent Biosolutions: 3,810 shares worth $206K.
  • Third Security added most to Precigen in Q4 2019, an estimated $2.99M increase.
  • Third Security's biggest Q4 2019 reduction was Halozyme, cutting an estimated $46.1M.
  • Third Security fully exited Fibrocell Science Inc. in Q4 2019, selling an estimated $4.89M.
  • Third Security's ten largest holdings make up 100% of its $620M portfolio in Q4 2019.
  • Third Security opened 1 new position and closed 1 in Q4 2019.
  • Third Security's portfolio value fell 7.1% quarter-over-quarter to $620M.

Based on Third Security's 13F filing for Q4 2019, filed 3 Feb 2020.